Literature DB >> 33204027

Mutational drivers of cancer cell migration and invasion.

Nikita M Novikov1, Sofia Y Zolotaryova1, Alexis M Gautreau2,3, Evgeny V Denisov4.   

Abstract

Genomic instability and mutations underlie the hallmarks of cancer-genetic alterations determine cancer cell fate by affecting cell proliferation, apoptosis and immune response, and increasing data show that mutations are involved in metastasis, a crucial event in cancer progression and a life-threatening problem in cancer patients. Invasion is the first step in the metastatic cascade, when tumour cells acquire the ability to move, penetrate into the surrounding tissue and enter lymphatic and blood vessels in order to disseminate. A role for genetic alterations in invasion is not universally accepted, with sceptics arguing that cellular motility is related only to external factors such as hypoxia, chemoattractants and the rigidity of the extracellular matrix. However, increasing evidence shows that mutations might trigger and accelerate the migration and invasion of different types of cancer cells. In this review, we summarise data from published literature on the effect of chromosomal instability and genetic mutations on cancer cell migration and invasion.

Entities:  

Mesh:

Year:  2020        PMID: 33204027      PMCID: PMC7784720          DOI: 10.1038/s41416-020-01149-0

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  210 in total

Review 1.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

2.  FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.

Authors:  Kaixuan Wang; Wenxiang Ji; Yongfeng Yu; Ziming Li; Xiaomin Niu; Weiliang Xia; Shun Lu
Journal:  Oncogene       Date:  2018-06-01       Impact factor: 9.867

Review 3.  Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

Authors:  Jonathan Cooper; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

4.  Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.

Authors:  Changyou Li; Ann Marie Egloff; Malabika Sen; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Oncol       Date:  2014-04-18       Impact factor: 6.603

Review 5.  RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis.

Authors:  Riccardo Di Fiore; Antonella D'Anneo; Giovanni Tesoriere; Renza Vento
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

6.  Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.

Authors:  Darawalee Wangsa; Isabel Quintanilla; Keyvan Torabi; Maria Vila-Casadesús; Amaia Ercilla; Gregory Klus; Zeynep Yuce; Claudia Galofré; Miriam Cuatrecasas; Juan José Lozano; Neus Agell; Daniela Cimini; Antoni Castells; Thomas Ried; Jordi Camps
Journal:  FASEB J       Date:  2018-02-08       Impact factor: 5.191

7.  The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.

Authors:  Molly R Ryan; Christal D Sohl; BeiBei Luo; Karen S Anderson
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

8.  Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.

Authors:  Emilia Dyczynska; Emilia Syta; Danqiong Sun; Anna Zolkiewska
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

Review 9.  New therapeutic strategies to treat human cancers expressing mutant p53 proteins.

Authors:  Giovanni Blandino; Silvia Di Agostino
Journal:  J Exp Clin Cancer Res       Date:  2018-02-15

10.  The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.

Authors:  Pirjo Åström; Krista Juurikka; Elin S Hadler-Olsen; Gunbjørg Svineng; Nilva K Cervigne; Ricardo D Coletta; Juha Risteli; Joonas H Kauppila; Sini Skarp; Samuel Kuttner; Ana Oteiza; Meeri Sutinen; Tuula Salo
Journal:  Br J Cancer       Date:  2017-08-03       Impact factor: 7.640

View more
  14 in total

1.  Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis.

Authors:  Chenmeng Li; Bei Pan; Xuhong Wang; Xiangxiang Liu; Jian Qin; Tianyi Gao; Huiling Sun; Yuqin Pan; Shukui Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-31       Impact factor: 4.322

2.  Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer.

Authors:  Di Wang; Biao Xie
Journal:  Eur J Med Res       Date:  2022-06-13       Impact factor: 4.981

Review 3.  Metastasis prevention: targeting causes and roots.

Authors:  A A Schegoleva; A A Khozyainova; T S Gerashchenko; L D Zhuikova; Evgeny V Denisov
Journal:  Clin Exp Metastasis       Date:  2022-03-26       Impact factor: 4.510

4.  Polarized interfacial tension induces collective migration of cells, as a cluster, in a 3D tissue.

Authors:  Satoru Okuda; Katsuhiko Sato
Journal:  Biophys J       Date:  2022-05-06       Impact factor: 3.699

5.  Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.

Authors:  Saptaparna Mukherjee; Martino Maddalena; YiQing Lü; Sebastien Martinez; Nishanth Belugali Nataraj; Ashish Noronha; Sansrity Sinha; Katie Teng; Victoria Cohen-Kaplan; Tamar Ziv; Sharathchandra Arandkar; Ori Hassin; Rishita Chatterjee; Anna-Chiara Pirona; Michal Shreberk-Shaked; Anat Gershoni; Yael Aylon; Zvulun Elazar; Yosef Yarden; Daniel Schramek; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-19       Impact factor: 12.779

Review 6.  The principles of directed cell migration.

Authors:  Shuvasree SenGupta; Carole A Parent; James E Bear
Journal:  Nat Rev Mol Cell Biol       Date:  2021-05-14       Impact factor: 94.444

Review 7.  Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors.

Authors:  Kaibo Guo; Yuqian Feng; Xueer Zheng; Leitao Sun; Harpreet S Wasan; Shanming Ruan; Minhe Shen
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

Review 8.  MicroRNA-375: potential cancer suppressor and therapeutic drug.

Authors:  Jiahui Wei; Yiran Lu; Ruiqing Wang; Xiangzhu Xu; Qing Liu; Song He; Huihao Pan; Xinmiao Liu; Bao Yuan; Yu Ding; Jiabao Zhang
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

Review 9.  Zebrafish Primordial Germ Cell Migration.

Authors:  Anne Aalto; Adan Olguin-Olguin; Erez Raz
Journal:  Front Cell Dev Biol       Date:  2021-06-23

10.  Circular RNA: A novel type of biomarker for glioma (Review).

Authors:  Wei Sun; Huandi Zhou; Xuetao Han; Liubing Hou; Xiaoying Xue
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.